Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:14 AM
Ignite Modification Date:
2025-12-26 @ 11:14 AM
NCT ID:
NCT04961528
Eligibility Criteria:
Inclusion Criteria:
* Patients over 18 years, under 90 years
* Mild to severe hemoptysis that has been going on for less than 7 days
* Total expectorate blood ranging from 50 ml to 200 ml
* Admission in emergency department or ICU for less than 12 hours
* Social security affiliation
* Signed informed consent
* For child-bearing aged women, efficient contraception includes oral oestrogen- progestin, oral progestin, progestin implants and all types of intrauterine devices
Exclusion Criteria:
* Need for mechanical ventilation
* Cystic fibrosis
* Pregnancy or breast feeding
* Contraindication for contrast agents injection (renal failure with creatinin clearance \< 30mL/min, know allergy to contrast agents injection)
* Known hypersensitivity to TXA or TER or one of its excipients
* Know previous cardiac arrhythmia (atrial fibrillation, atrial flutter..)
* Contraindication to TXA (including renal failure with creatinin clearance \< 30mL/min) or TER therapy :
* acute myocardial infarction in the 6 past months,
* intrathecal injection in the 3 past months,
* seizure in the past 3 months
* Participation in another interventional study or being in the exclusion period at the end of a previous study.
* Patient under tutorship or / guardianship, and incapable to give informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT04961528
Study Brief:
Protocol Section:
NCT04961528